TD Asset Management’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-78,034
| Closed | -$1.03M | – | 1257 |
|
|
2024
Q4 | $1.03M | Hold |
78,034
| – | – | ﹤0.01% | 1105 |
|
|
2024
Q3 | $883K | Sell |
78,034
-34,214
| -30% | -$387K | ﹤0.01% | 1211 |
|
|
2024
Q2 | $1.21M | Hold |
112,248
| – | – | ﹤0.01% | 1129 |
|
|
2024
Q1 | $1.67M | Hold |
112,248
| – | – | ﹤0.01% | 1064 |
|
|
2023
Q4 | $2.03M | Hold |
112,248
| – | – | ﹤0.01% | 1003 |
|
|
2023
Q3 | $1.95M | Buy |
112,248
+56,124
| +100% | +$973K | ﹤0.01% | 965 |
|
|
2023
Q2 | $1.02M | Buy |
56,124
+5,300
| +10% | +$96K | ﹤0.01% | 1130 |
|
|
2023
Q1 | $1.35M | Buy |
50,824
+21,264
| +72% | +$566K | ﹤0.01% | 1082 |
|
|
2022
Q4 | $571K | Hold |
29,560
| – | – | ﹤0.01% | 1263 |
|
|
2022
Q3 | $614K | Buy |
+29,560
| New | +$614K | ﹤0.01% | 1258 |
|
|
2021
Q3 | – | Sell |
-14,442
| Closed | -$292K | – | 1549 |
|
|
2021
Q2 | $292K | Hold |
14,442
| – | – | ﹤0.01% | 1446 |
|
|
2021
Q1 | $568K | Buy |
+14,442
| New | +$568K | ﹤0.01% | 1378 |
|